Among over 500 obese patients with OSAS, long-term tirzepatide treatment led to significant reductions in body weight, AHI, and oxygen desaturation index, with particularly pronounced benefits in patients with concurrent glucose and lipid metabolism abnormalities (52)
Older adults, those with liver disease, alcohol use, malnutrition, CYP2E1 genetic variations, and users of other hepatotoxic drugs face higher depletion risk
It is unknown whether Wegovy causes thyroid C-cell tumors in humans
Concentrates remain suitable in formats where total calorie intake is not the limiting factor
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose